US Patent Issued to Vikas Kundra on July 28 for "Somatostatin receptor-based cancer therapy" (Maryland Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,179, issued on July 28, was assigned to Vikas Kundra (Bethesda, Md.).

"Somatostatin receptor-based cancer therapy" was invented by Vikas Kundra (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for cell-based therapy as well as somatostatin receptor-based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a signaling defective somatostatin receptor mutant are described. Furthermore, the invention provides compositions and methods involve a somatostatin constitutively active somatostatin receptor mutant."

The patent was filed on Jan. 3, 2023, under Applicat...